Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

Tegally, Houriiyah, Wilkinson, Eduan, Giovanetti, Marta, Iranzadeh, Arash, Fonseca, Vagner, Giandhari, Jennifer, Doolabh, Deelan, Pillay, Sureshnee +39 more·2020·Nature
DOI 10.1101/2020.12.21.20248640

Cited by (1,009)

Items 901–1,000 of 1,009

  1. Establishing an internal quality control method for the stable extraction of nucleic acids of severe acute respiratory syndrome coronavirus 2 and RT‐PCR‐based detection
    Takahiro Okuyama, K. Ohtsuka, W. Ogura · 2021 · Journal of clinical laboratory analysis (Print)
  2. Single-Dose SARS-CoV-2 Vaccination With BNT162b2 and AZD1222 Induce Disparate Th1 Responses and IgA Production
    Michael Müller, Johann Volzke, Behnam Subin · 2021 · medRxiv
  3. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity
    V. Kouamou, Richard Matarise, Elizabeth Sabino dos Santos · 2021 · The Pan African Medical Journal
  4. Emerging COVID-19 vaccines: safety, efficacy and universality
    Khadija El Azhari, Kenza Miyara, Saadia Ait Ssi · 2021
  5. Emergence of a putative novel SARS-CoV-2 P.X lineage harboring N234P and E471Q spike protein mutations in Southern Brazil
    Mariana Soares da Silva, Juliana Schons Gularte, Meriane Demoliner, Alana Witt Hansen, Fágner Henrique Heldt, Micheli Filippi, Cristiane Borba Luckmann, Flávio Silveira, Vyctoria Malayhka de Abreu Góes Pereira, Rodrigo de Almeida Vaucher et al. · 2021 · Research Square
  6. Evolution of resistance to COVID-19 vaccination with dynamic lockdown
    M. Nowak, Gabriela Lobinska, Ady Pauzner · 2021
  7. Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 Variants
    Larisa Troitskaya, Nelson L.S. Chan, Brendon T. Frank · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Airborne PM2.5 and the Emergence of 10 SARS-CoV-2 Variants: The Multifaceted Influence of an Airborne Pollutant on Viral Natural Selection determining SARS-CoV-2 Evolution - An Environmental Wake-up Call or an Ecological Fallacy?
    Yves Muscat Baron · 2021 · medRxiv
  9. Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
    G. Cerutti, Yi-Cheng Guo, Pengfei Wang, M. Nair, Yao-Xing Huang, J. Yu, Li-Hong Liu, P. Katsamba, F. Bahna, E. Reddem et al. · 2021 · bioRxiv
  10. Mask-off policy in the shadow of emerging variants of SARS-COV-2
    A. Shahraki, M. Vahed, M. Mirsaeidi · 2021 · European journal of internal medicine
  11. Epidemiological characteristics and incubation period of SARS‐CoV‐2 during the 2020–2021 winter pandemic wave in North China: An observational study
    Tiantian Liu, Zijian Chen, Jin Xu · 2021 · Journal of Medical Virology
  12. Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost
    Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Alec P. Pankow, Natalie L. Smith, Xaquín Castro Dopico, Gerald M. McInerney et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  13. SARS-CoV-2 rapid antigen detection tests – Authors' reply
    R. Peeling, P. Olliaro, D. Boeras · 2021 · Lancet. Infectious Diseases (Print)
  14. SARS-CoV-2 Infection Elicits a Greater Humoral Immune Response in the Second Wave Than the First Wave
    Sayeh Ezzikouri, Hind Majidi, Soad Redwane, Nadia Meziane, Abdellatif Zahir, Islam Abbadi, Chaimaa Zerrad, Asmaa Haddaji, Karima Abounouh, Soufiane Hilmi et al. · 2021 · Research Square
  15. SARS-CoV-2 UK, South African and Brazilian Variants in Karachi- Pakistan
    Adnan Khan, Muhammad Hanif, Sarosh Syed, Akhtar Ahmed, Saqib Ghazali, Rafiq Khanani · 2021 · Frontiers in Molecular Biosciences
  16. Genes of SARS-CoV-2 and emerging variants
    Sudip Dhakal, I. Macreadie · 2021
  17. Inferring the main drivers of SARS-CoV-2 transmissibility
    Marko Djordjevic, Igor Salom, S. Markovic · 2021
  18. Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants
    Anni Ge, Melissa L. Rioux, Alyson A. Kelvin · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Meta-Analysis of the Dynamics of the Emergence of Mutations and Variants of SARS-CoV-2
    Nicolas Castonguay, Wan-Dong Zhang, Marc-André Langlois · 2021 · medRxiv
  20. Sequence Analysis of 20,453 SARS-CoV-2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern
    S. Long, R. Olsen, P. Christensen et al. · 2021 · medRxiv
  21. Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key
    S. Al Awaidy, R. Asghar, Saad Omais · 2021 · Oman Medical Journal
  22. SARS-CoV-2 Mutations in Brazil: From Genomics to Clinical Conditions
    L. F. S. M. Timmers, Julia Peixoto, R. Ducati et al. · 2021
  23. SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of October 2020 to February 2021 – implementation of Swiss-wide diagnostic screening and whole genome sequencing
    Tim Roloff Ana Rita Goncalves Cabecinhas, Claire Bertelli Madlen Stange, Alban Ramette Michael Huber et al. · 2021 · medRxiv
  24. Increased SAR-CoV-2 shedding associated with reduced disease severity despite continually emerging genetic variants
    Cynthia Y. Tang, Yang Wang, Cheng Gao, David R. Smith, Jane A. McElroy, Tao Li, Karen M. Segovia, Tricia Haynes, Richard Hammer, Christopher Scott Sampson et al. · 2021 · medRxiv
  25. Rapid vaccination and early reactive partial lockdown will minimize deaths from emerging highly contagious SARS-CoV-2 variants
    D. Reeves, C. Bracis, David A. Swan · 2021 · medRxiv
  26. Molecular dynamics simulation study reveals effects of key mutations on spike protein structure in SARS-CoV-2
    Jerome Rumdon Lon, Binbin Xi, Bingxu Zhong, Yiyuan Zheng, Zixi Chen, Ruoran Qiu, Siqing Zhang, Pei Guo, Hongli Du · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  27. The basis of a more contagious 501Y.V1 variant of SARS-COV-2
    Hao-Lin Liu, Qian-Qian Zhang, Pengcheng Wei et al. · 2021 · bioRxiv
  28. Epidemic overdispersion strengthens the effectiveness of mobility restrictions
    Gerrit Großmann, Michael Backenköhler, V. Wolf · 2021 · medRxiv
  29. The Relationship Between the Global Burden of Influenza From 2017 to 2019 and COVID-19: Descriptive Epidemiological Assessment
    Stefan Baral, Katherine B. Rucinski, Jean Olivier Twahirwa Rwema, Amrita Rao, Neia Prata Menezes, Daouda Diouf, Adeeba Kamarulzaman, Nancy Refilwe Phaswana-Mafuya, Sharmistha Mishra · 2021 · JMIR Public Health and Surveillance
  30. Epidemiology of COVID-19 in Latin America
    Alfonso Javier Rodriguez-Morales, D. Katterine Bonilla‐Aldana · 2021 · Elsevier eBooks
  31. Comparison of case and control groups in terms of postoperative complications, outcomes, and survival in total hip arthroplasty patients with and without COVID-19
    Fadime Çınar, Semra Bülbüloğlu · 2023 · Frontiers in Medicine
  32. Different immunological responses following immunization with two mRNA vaccines
    Tetsuo Nakayama, Reiko Takai‐Todaka, Akihito Sawada, Takashi Ito, Motoko Fujino, Kei Haga, Kazuhiko Katayama · 2023 · Journal of Infection and Chemotherapy
  33. The macroeconomic and epidemiological impacts of Covid-19 in Pakistan
    Henning Tarp Jensen, Marcus Richard Keogh-Brown, Rosalind M. Eggo, Carl A. B. Pearson, Sergio Torres Rueda, Maryam Huda, Muhammad Khalid, Wahaj Zulfiqar, CMMID COVID-19 Working Group, Richard Smith et al. · 2023 · medRxiv
  34. An updated research focus on the employment of computer-aided drug discovery and repurposing techniques for the identification and evaluation of SARS-CoV-2 Main protease inhibitors: A protocol for a systematic review and meta-analysis
    Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha · 2023 · medRxiv
  35. An update on vaccine status and the role of nanomedicine against SARS‐CoV‐2: A narrative review
    Rabeya Tajnur, Refaya Rezwan, Abdul Aziz, Mohammad Safiqul Islam · 2023 · Health Science Reports
  36. Travel history among persons infected with SARS-CoV-2 variants of concern in the United States, December 2020—February 2021
    Alicia Dunajcik, Kambria Haire, Jennifer Dolan Thomas, Leah F. Moriarty, Yuri P. Springer, Julie M. Villanueva, Adam MacNeil, Benjamin J. Silk, Jeffrey B. Nemhauser, Ramona Byrkit et al. · 2023 · PLOS Global Public Health
  37. Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19
    Muneerah Smith, Gaurav Kwatra, Alane Izu, Andrew J. M. Nel, Clare Cutland, Khatja Ahmed, Vicky Lynne Baillie, Shaun Lawrence Barnabas, Qasim Ebrahim Bhorat, Carmen Briner et al. · 2023 · Viruses
  38. Motifs in SARS-CoV-2 evolution
    Christopher L. Barrett, Andrei C. Bura, Qi-Jun He · 2023 · bioRxiv
  39. Identification of genomic signatures and multiple lineage markers from the second and third wave samples of COVID-19 in Western Rajasthan, India
    Naveen Prakash Bokolia, Ravisekhar Gadepalli · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Assessment of Jordanian health care professionals’ perception towards new COVID-19 variants of concern
    H. M. Sawan, S. M. Al Omari, F. Al Bahar · 2022 · PLoS ONE
  41. Characteristics and outcomes of SARS-COV 2 critically ill patients after emergence of the variant of concern 20H/501Y.V2: A comparative cohort study
    P. Ariés, O. Huet, J. Balicchi et al. · 2022 · Medicine
  42. Novel Mutations Associated with N-Gene Target Failure in SARS-COV-2 Genome in Iran, Case Series
    Ali Maleki, Zahra Fereydouni, Mahsa Tavakoli · 2022 · Journal of Medical Microbiology and Infectious Diseases
  43. STArS (STrain-Amplicon-Seq), a targeted nanopore sequencing workflow for SARS-CoV-2 diagnostics and genotyping
    Simone Maestri, Valentina Grosso, Massimiliano Alfano, Denise Lavezzari, Chiara Piubelli, Zeno Bisoffi, Marzia Rossato, Massimo Delledonne · 2022 · Biology Methods and Protocols
  44. Development of an efficient reproducible cell-cell transmission assay for rapid quantification of SARS-CoV-2 spike interaction with hACE2
    George Ssenyange, M. Kerfoot, Min Zhao, S. Farhadian, Si-Di Chen, Lei Peng, Ping Ren, C. Dela Cruz, Shaili Gupta, Richard E. Sutton · 2022 · Cell Reports Methods
  45. Outbreak of Severe Acute Respiratory Syndrome Coronavirus-2 B.1.620 Lineage in the General Hospital of Jeju Island, Republic of Korea
    Young‐Ran Ha, Een-suk Shin, Hyun Jeong Kim, Eun-Hwa Hyeon, Jae‐Sung Park, Yoon‐Seok Chung · 2022 · Frontiers in Microbiology
  46. Development of PCR test for detection of the SARS-CoV-2 genetic variants alpha, beta, gamma, delta
    German Alexandrovich Shipulin, Yuliya A. Savochkina, Шуряева Анна Константиновна, EE Shivlyagina, A.O. Nosova, Давыдова Екатерина Евгеньевна, Andrey R. Luparev, Малова Татьяна Владимировна, Sergei M. Yudin · 2022 · Medicine of Extreme Situations
  47. Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
    Samuel Lebourgeois, Houssem Redha Chenane, Nadhira Houhou‐Fidouh, Reyene Menidjel, Valentine Marie Ferré, Gilles Collin, Nabil Benmalek, Romain Coppée, Lucile Larrouy, Yazdan Yazdanpanah et al. · 2021 · Frontiers in Cellular and Infection Microbiology
  48. ClusTRace, a bioinformatic pipeline for analyzing clusters in virus phylogenies
    I. Plyusnin, P. T. Truong Nguyen, T. Sironen · 2021 · BMC Bioinformatics
  49. Epidemiological Analysis of SARS-CoV-2 Transmission Dynamics in the State of Odisha, India: A Yearlong Exploratory Data Analysis
    Sourya Subhra Nasker, Ananya Nanda, Balamurugan Ramadass, Sasmita Nayak · 2021 · International Journal of Environmental Research and Public Health
  50. SARS-CoV-2 variant transmission in a community-health population (Mexico City, Mexico)
    Wenjuan Zhang, Marcela Martinez, Brian D Davis, Stephanie S. Chen, Jorge Martínez, Clara Corona, Guadalupe del Rocío Lagua Díaz, Elias P. Makhoul, Saleh G. Heneidi, Jorge Goldberg et al. · 2021 · medRxiv
  51. Spatiotemporal analyses illuminate the competitive advantage of a SARS-CoV-2 variant of concern over a variant of interest
    Alexis Russell, Collin O’Connor, Erica Lasek‐Nesselquist, Jonathan Plitnick, John P. Kelly, Daryl M. Lamson, Kirsten St. George · 2021 · medRxiv
  52. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis
    Tawanda Chivese, Joshua T. Matizanadzo, Omran A. H. Musa et al. · 2021 · medRxiv
  53. Real-time Reverse Transcription PCR-based SARS-CoV-2 Detection in Khwaja Yunus Ali Medical College Hospital, Enayetpur, Sirajganj, Bangladesh
    M. A. Rahman, S. Sultana, Mosammad Alpana Jahan · 2021 · KYAMC Journal
  54. Mutations that adapt SARS-CoV-2 to mustelid hosts do not increase fitness in the human airway.
    Jie Zhou, T. Peacock, Jonathan C. Brown et al. · 2021
  55. Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children’s hospital before second pandemic wave in Germany
    Marietta Neumann, Annette Aigner, Eileen Rossow, David Schwarz, Maria Marschallek, Jörg Steinmann, Ralf Stücker, Ingo Königs, Philippe Stock · 2021 · World Journal of Pediatrics
  56. Whole Genome Sequencing Analysis of Spike D614G Mutation Reveals Unique SARS-CoV-2 Lineages of B.1.524 and AU.2 in Malaysia
    Ummu Afeera Zainulabid, Aini Syahida Mat Yassim, Sharmeen Nellisa Soffian · 2021 · medRxiv
  57. The rise and fall of an emerging SARS-CoV-2 variant with the spike protein mutation L452R
    O. Mor, M. Mandelboim, Shay Fleishon · 2021 · medRxiv
  58. Real-time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with Variants of Concern
    Mariana Abdulnoor, A. Eshaghi, Stephen J. Perusini et al. · 2021 · medRxiv
  59. Relevance of prediction scores derived from the SARS-CoV-2 first wave, in the UK COVID-19 second wave, for early discharge, severity and mortality: a PREDICT COVID UK prospective observational cohort study
    Hakim Ghani, Alessio Navarra, Phyoe Kyaw Pyae, Harry Mitchell, William Kenneth Evans, Rigers Cama, Michael Shaw, Ben Critchlow, Tejal Vaghela, Miriam Schechter et al. · 2021 · medRxiv
  60. Monitoring of SARS-CoV-2 B.1.1.7 variant early-phase spreading in South-Moravian Region in the Czech Republic and evaluation of its pathogenicity
    Daniel Diabelko, Milada Dvořáčková, Monika Dvořáková, Giancarlo Forte, Ivan Čundrle, Filip Růžička, Jan Vrbský · 2021 · medRxiv
  61. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study
    Sonia Beeckmans, Edilbert VAN DRIESSCHE · 2021 · Frontiers in Molecular Biosciences
  62. The SARS-CoV-2 B.1.351/V2 variant is outgrowing the B.1.1.7/V1 variant in French regions in April 2021
    B. Roquebert, S. Trombert-Paolantoni, S. Haim-Boukobza · 2021 · medRxiv
  63. SARS-CoV-2 convergent evolution cannot be reliably inferred from phylogenetic analyses
    Yoon-Seo Jo, Asif U. Tamuri, Greg J. Towers, Richard A. Goldstein · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Allosteric Cross-Talk Among SARS-CoV-2 Spike’s Receptor-Binding Domain Mutations Triggers an Effective Hijacking of Human Cell Receptor
    A. Spinello, Andrea Saltalamacchia, J. Borišek · 2021 · bioRxiv
  65. The Impact of SARS-CoV-2 Variants on Morbidity, Mortality and Effectiveness of Vaccines
    Kenan Midilli · 2021 · Infectious Diseases and Clinical Microbiology
  66. Unlocking capacities of viral genomics for the COVID-19 pandemic response
    Sergey Knyazev, Karishma Chhugani, Varuni Sarwal, Ram Ayyala, Singh, Harman, Smruthi Karthikeyan, Dhrithi Deshpande, Zoia Comarova, Angela Lu, Yuri B. Porozov et al. · 2021 · PubMed
  67. A Review of COVID-19 Vaccines: What Needs to Be Known and Its Expected Effect on the Human Population?
    Syahrul Tuba, Widyati Widyati, Syed Azhar Syed Sulaiman · 2021 · Preprints.org
  68. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a widely used commercial multiplex PCR assay
    Paul Wollschlaeger, Nadja Gerlitz, Daniel Todt et al. · 2021 · medRxiv
  69. Epidemic trends of SARS-CoV-2 modulated by economic activity, ethnicity, and vaccination
    Yasuhiko Kamikubo, Atsushi Takahashi · 2021
  70. COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival.
    S. Dispinseri, M. Secchi, M. Pirillo et al. · 2021 · medRxiv
  71. Infection à VIH et vaccination anti-SARS-Cov2
    2021 · Bulletin de l'Académie Nationale de Médecine
  72. Impfstoffentwicklung zur Prävention von COVID-19 – Teil 2
    M. Augustin, M. Hallek, S. Nitschmann · 2021 · Der Internist
  73. Mandatory COVID-19 vaccination for oral health professionals (OHPs) - Ethical appraisal
    Thembelihle M Mtolo, Pagollang D Motloba, Neil Hamilton Wood · 2021 · South African Dental Journal
  74. Características clínicas de COVID-19 en trabajadores sanitarios de tres hospitales de Madrid durante la primera ola de la pandemia
    Ámbar Deschamps-Perdomo, Mayra Garrafa-Núñez, María Eva Meza-Caballero · 2021 · Medicina y Seguridad del Trabajo
  75. Liver Injury in COVID-19 Patients: An Overview of the Current Evidence
    T. Balzano, O. el Hiba, N. L. del Rey, Souad El Amine, Kamal Smimih · 2022
  76. SARS-CoV-2 most concerning variants: A review on their complications, pathogenicity, transmissibility, and immune responses
    Zeinab Mohseni Afshar · 2022 · Eurasian Journal of Pulmonology
  77. SARS-CoV-2 Mutations and their Viral Variants
    Begüm Coşar, Zeynep Yağmur KARAGÜLLEOĞLU, Sinan ÜNAL, Ahmet Turan İnce, Dilruba Beyza Uncuoglu, Gizem Tuncer, Bugrahan Regaip Kilinc, Yunus Emre Ozkan, Hikmet Ceyda Ozkoc, Ibrahim Naki Demir et al. · 2021 · Cytokine & Growth Factor Reviews
  78. High-Potency Polypeptide-based Inhibition of Enveloped-virus Glycoproteins
    Jianpeng Ma, Adam Campos Acevedo, Qinghua Wang · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  79. In Silico and in vitro evaluation of Cucurbitaceae seed lectins as promising prophylactic and therapeutic agents against SARS-CoV-2
    Rumana Ahmad, Yusuf Akhter, Varsha Varsha, Tanveer Ahamad, Aditi Srivastava, Kusum Yadav, Sahabjada Siddiqui, D. Himanshu Reddy, Ankita Rajesh Gupta, Yashi Nigam et al. · 2025 · Glycoconjugate Journal
  80. Development and validation of predictive models for mortality of cases with COVID-19 (Omicron BA.5.2.48 and B.7.14): a retrospective study
    Peifang Li, Huiliang Yang, Jinyu Wu, Yanfei Ma, Ailin Hou, Jiali Chen, Ning Ning · 2024 · BMJ Open
  81. Investigation of COVID-19 virus mutagenicity and the effect of the NSP13, NSP14, and NSP16 on the -1 ribosomal frameshifting
    Ali Khanifar, Azin Najafi, Jaber Hemmati, Fatemeh Nouri, Seyed Ali Hosseini, Mohammad Taheri · 2024 · Frontiers in Virology
  82. Extracellular and intracellular antiviral effects of ultraviolet A against severe acute respiratory syndrome coronavirus-2 are variant-independent
    Gabriela Leite, Sepideh Mehravar, Mark Pimentel, Ruchi Mathur, GIL Y. MELMED, Volha Teagle, Gillian M. Barlow, Ali Ranjideh Rezaie · 2024 · Photodiagnosis and Photodynamic Therapy
  83. World Pandemic Control in International Law: Through a Transboundary Harm Perspective
    Doudou Huang · 2023 · Netherlands International Law Review
  84. A deep learning framework for predicting the neutralizing activity of COVID-19 therapeutics and vaccines against evolving SARS-CoV-2 variants
    Robert P. Matson, Işın Y. Comba, Eli Silvert, Michiel J.M. Niesen, Karthik Murugadoss, Dhruti Padwardhan, Rohit Suratekar, Elizabeth-Grace Goel, Brittany J. Poelaert, Kanny K. Wan et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Comparing SARS-CoV-2 sequencing methodologies during early phase detection of the Delta variant in South Africa
    Upasana Ramphal, T. de Oliveira · 2023 · The Global Health Network Conference Proceedings 2022
  86. On-Site Sequencing Of Sars-Cov-2 Genomes Identify Two Variant Of Concern Clusters In Pahang, Malaysia
    H. F. Ahmad, U. A. Zainulabid, Wan Nurliyana Wan Ramli · 2023 · Current Science and Technology
  87. Lessons that can be learned from the SARS-CoV-2 pandemic and their impact on the prophylaxis and treatment development for neglected tropical arboviruses
    Danilo Rosa Nunes, Danilo Bancalero Mendonça Lucchi, Robert Andreata‐Santos, Luiz Mário Janini, Carla Torres Braconi · 2023 · Frontiers in Drug Discovery
  88. Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections
    L. Martínez-Sobrido, J. Kobie · 2023 · Antibodies
  89. Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa
    M. Yousif, Saïd Rachida, Setshaba Taukobong et al. · 2022 · medRxiv
  90. Detection of SARS-CoV-2 from Indonesia with colorimetric saliva based RT-LAMP method using thermal cycler
    Arif Bimantara, Ika Afifah Nugraheni, L. Rosida · 2022 · International Journal of Health Science and Technology
  91. Rapid threat detection in SARS-CoV-2
    Christopher L. Barrett, Fenix W. D. Huang, Thomas J. X. Li, Andrew S. Warren, Christian M. Reidys · 2022 · medRxiv
  92. Laboratory diagnosis of emerging human infections by SARS-COVID-19: Prevalence and challenges
    Soumya Nigam, Urvashi Vijay, Bhumandeep Kour · 2022 · Novel Research in Microbiology Journal
  93. Clinical and Genetic Characteristics of Coronaviruses with Particular Emphasis on SARS-CoV-2 Virus
    Joanna Iwanicka, Tomasz Iwanicki, Marcin Kaczmarczyk, Włodzimierz Mazur · 2022 · Polish Journal of Microbiology
  94. Comparative Analysis of the Implication of Periods Before and During Vaccination of COVID-19 Infection in Some Regional Leading African Countries
    Abiola T. Owolabi, Kayode Ayinde, Taiwo Joel Adejumo, Wakeel A. Kasali, Emmanuel Taiwo Adewuyi · 2022 · Journal of the Nigerian Society of Physical Sciences
  95. Detection of SARS-CoV-2 N501Y Mutation Among SARS-CoV-2 Variants of Concern Circulating in Northern Cyprus
    Gülten Tuncel, Mahmut Çerkez Ergören, Buket Baddal, Pınar Tulay, Cenk Serhan Özverel, Emrah Güler, Hüseyin Kaya Süer, Murat Sayan, Tamer Şanlıdağ · 2022 · Future Virology
  96. nSARS-CoV-2 and COVID-19 Pandemic: From Emergence to Vaccination
    Imran Shahid · 2022 · Dr Sulaiman Al Habib Medical Journal
  97. Molecular Dynamics Simulations Studies On The Effects Of Mutations On The Binding Affinities Between SARS-CoV-2 Spike RBD And Human ACE2
    Smriti Arora, Jeevan Patra · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Predicting Variant-Driven Multi-Wave Pattern of COVID-19 via a Machine Learning Analysis of Spike Protein Mutations
    Adele de Hoffer, Shahram Vatani, Corentin Cot, Giacomo Cacciapaglia, Maria Luisa Chiusano, Andrea Cimarelli, F. Conventi, Antonio Giannini, Stefan Hohenegger, Francesco Sannino A · 2021 · Research Square
  99. The Potential Use of Cyclosporine Ultrafine Solution Pressurised Metered- Dose Inhaler in the Treatment of COVID-19 Patients
    Touraj Ehtezazi · 2021 · Recent Advances in Drug Delivery and Formulation
  100. Downsizing of contact tracing during COVID-19 vaccine roll-out
    M. Martignoni, Josh Renault, Joseph Baafi · 2021 · medRxiv